Compare HRMY & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | RLJ |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | N/A | 75 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2020 | N/A |
| Metric | HRMY | RLJ |
|---|---|---|
| Price | $37.03 | $11.78 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 6 |
| Target Price | ★ $44.11 | $7.83 |
| AVG Volume (30 Days) | 854.1K | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 7.26% |
| EPS Growth | ★ 7.97 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $868,453,000.00 | N/A |
| Revenue This Year | $19.75 | $2.02 |
| Revenue Next Year | $12.88 | $2.54 |
| P/E Ratio | ★ $67.75 | $188.67 |
| Revenue Growth | ★ 21.51 | N/A |
| 52 Week Low | $25.52 | $6.54 |
| 52 Week High | $40.87 | $12.11 |
| Indicator | HRMY | RLJ |
|---|---|---|
| Relative Strength Index (RSI) | 68.61 | 75.94 |
| Support Level | $35.05 | $7.24 |
| Resistance Level | $39.12 | N/A |
| Average True Range (ATR) | 1.04 | 0.30 |
| MACD | 0.22 | -0.03 |
| Stochastic Oscillator | 93.53 | 72.37 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.